Document is current
Any future updates will be listed below
-
Authors
Fong, Caroline http://orcid.org/0000-0002-4409-9466
Johnston, Edwina http://orcid.org/0000-0001-5344-7971
Starling, Naureen http://orcid.org/0000-0002-1496-6792
- License Information
-
More Information
Article History
Accepted: 14 July 2022
First Online: 18 August 2022
Declarations
:
: C. Fong: Honoraria - Bristol Myers SquibbE. Johnston: NoneN. Starling: Research funding - AstraZeneca, BMS, Pfizer, NIHR EME, RMCC, RM/ICR BRC, Merck; travel and accommodation - AstraZeneca, BMS, Eli Lilly, Merck, Roche, MSD Oncology; honoraria - Eli Lilly, Merck Serono, MSD Oncology, Pierre Fabre, Servier, GSK, Amgen, Lilly Bangladesh, Lilly Thailand, Novartis, Servier, Clinical Options; advisory board - Pfizer, AstraZeneca, Servier, MSD (Merck), MSD Oncology, Novartis, GSK
: This article does not contain any studies with human or animal subjects performed by any of the authors.
